Trial Profile
Influence of the Acidic Beverage Cola on the Absorption of the HCV Agent Velpatasvir in Healthy Volunteers Being Treated With the Proton Pump Inhibitor Omeprazole.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary) ; Omeprazole
- Indications Hepatitis C
- Focus Pharmacokinetics
- Acronyms COPA
- 17 Jul 2019 Results published in the Clinical Pharmacology and Therapeutics
- 21 Jan 2019 Status changed from not yet recruiting to completed.
- 04 May 2018 New trial record